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Van Eeden, Stephan F., Simon Bicknell, Blair A. M. Walker, and James C. Hogg. Polymorphonuclear leukocytes L-selectin expression decreases as they age in circulation. Am. J. Physiol. 272 (Heart Circ. Phvsiol. 41): H401-H408,1997.-We recently reported that L-selectin expression increases on circulating polymorphonuclear leukocytes (PMN) during active bone marrow release, which suggests that older cells in the circulation have lower levels of L-selectin than those recently released from the bone marrow. The present study was designed to test the hypothesis that L-selectin expression reduces on PMN as they age in the circulation.
In vitro studies using flow cytometry showed that PMN Lselectin decreased to 14.6 -+ 2.3'2 of baseline during a 24-h incubation at 37°C. To test this hypothesis in vivo, rabbit PMN, labeled in vivo with 5'-bronco-2-deoxyuridine (PMN-13~'(11-) in donor animals, were infused into recipient rabbits as whole blood (12 = 5 1 and followed over 24 h in the circulation with a double imnunolabeling technique. These results showed that the fraction of the L-selectin-negative PMN131'r11T in the circulation increased with time CP < O.OOl), and nearly all of the PMNH1* (lt-' in the circulation were L-selectin negative after 24 h. Removal of L-selectin from the surface of PMN13*'(11T with chyrnotrypsin before infusion did not change their rate of removal from the circulation (half-life or tliY 262 vs. 296 min, P = NS). We conclude that there is a continuous loss of L-selectin from PMN during their life span in the circulation, which supports the hypothesis that L-selectin expression decreases on PMN as they age.
neutrophils;
cell adhesion molecules; neutrophil kinetics RECENT STUDIES have shown that the migration of polymorphonuclear leukocytes (PMN> out of the vasculature is preceded by the rolling on the endothelium of postcapillary venules (18, 291 . This rolling phenomenon is mediated by receptors called selectins ( 18), which include three related membrane proteins that interact with cell-surface fucosylated carbohydrate ligands ( 16 1. One of these selectins, L-selectin (CD62L), is expressed on most leukocytes and has been shown to mediate rolling of rabbit, rat, and human PMN in mesenteric venules (18, 29) . This rolling phenomenon is more pronounced on inflamed venules and allows the PMN to slow down under shear force in postcapillary or collecting venules (17, 21). Rolling is followed by either a return of the PMN to the circulation or by firm adherence in preparation for migration out of the vascular space. This latter event is mediated by the activationinduced increases in avidity of the integrins for their immunoglobulin(Ig)-like counterreceptors, intercellular adhesion molecules 1 and 2, on the endothelial cell surface (5 1.
L-selectin is removed from the PMN surface via endoproteolytic cleavage by a membrane bond protease with relaxed sequence specificity (6, 15, 25) . Stimulation of PMN with activating agents and phorbol esters results in immediate receptor shedding (15, 23, 25) . Several investigators (6, 15) have suggested that the shedding of L-selectin could provide a means for the de-adhesion of PMN, allowing them to return to the circulation when the signal for firm adhesion is insuficient or alternatively reduces PMN adherence to endothelium as the cells migrate into subendothelial tissues. L-selectin can be found in the supernatant of cultured lymphocytes (23) and can be demonstrated free in the plasma (22 1, suggesting that L-selectin may be constitutively lost from circulating leukocytes. This constitutive shedding of L-selectin has been demonstrated in lymphocytes and can be reexpressed by de novo synthesis. In contrast to lymphocytes, circulating PMN have reduced ability to resynthesize L-selectin (23).
We recently showed (28) that the mature PMN in the postmitotic pool in the bone marrow express high levels of L-selectin with a lower and more variable expression on circulating PMN. This led us to hypothesize that PMN in the circulation shed their L-selectin as they age. The purpose of the present study was to determine whether the lower expression on circulating PMN is due to a continuous shedding of L-selectin as PMN age in the circulation.
METHODS
Blood from female New Zealand White rabbits was used for in vitro studies. All studies were approved by the Animal 
Cell Preparation
Brd U labeling ofdonor PMN. The DNA of rabbit leukocytes was labeled with 5'-bromo-2'-deoxyuridine (BrdU), a thymidine analogue, with the use of a previously described method (2). Five donor rabbits were given BrdU (Sigma) at a dose of 25 mg/kg daily for 7 days. The BrdU was infused through the marginal ear vein at a concentration of 5 mg/ml in normal saline over 15 min. Each day 1 ml of blood was collected from the central ear artery in tubes (Vacutainer, Becton-Dickinson) containing EDTA. Blood cell counts were determined on a model SS80 Coulter Counter (Coulter), and differential white cell counts were performed by counting 100 leukocytes on a randomly selected field on Wright%-stained blood smears. An additional 2-ml sample was collected in ACD for the preparation of leukocyte-rich plasma (LRP) using highmolecular-weight (lOO,OOO-200,000) dextran, final concentration 1.9% dextran wt/vol (Chemical Dynamics) to sediment red blood cells for 25-30 min. The LRP obtained was cytospun onto 3-aminopropyl-triethoxysilane-coated slides by cytocentrifugation at 180 g on a Cytospin 2 (Shandon Lab Products, Chestire, UK) for 4 min. The specimens were diluted with PMN buffer 1: 1 (in mM: 138 NaCl, 27 KCl, 8.1 NaHzP04 l 7Hz0, 1.5 KHzP04, 5 glucose, pH 7.4) or further if necessary to obtain a single layer of cells on the slide. The cytospin specimens were air dried and stained using the alkaline phosphatase and anti-alkaline phosphatase (APAAP) method (7) to determine the fraction of the BrdU-labeled PMN in each specimen (2).
PMN purification. The PMN were purified from donor rabbit blood by a previously described method (8). Briefly, the LRP obtained from 75 ml of donor blood was centrifuged and resuspended in 1 ml PMN buffer. Hypotonic lysis of the residual red blood cells in the LRP was achieved by dilution with 11 ml of sterile water. After 18 s, 11 ml 2~ PBS (2x PBS is 27 mM NazHP04, 132 mM KHzP04, and 2.74 M NaCl) and 10 ml PMN buffer were added. The PMN were separated from the mononuclear cells by centrifugation in Histopaque (Sigma) with a density of 1.077 g/ml at 250 g for 13 min. The isolated PMN were 95-98s pure with a viability of 97%, as assessed by trypan blue exclusion.
Removal of L-selectin by chymotrypsin treatment of PMN. Selective removal of L-selectin from the PMN by chymotrypsin allowed us to study the behavior of a population of predominantly L-selectin-negative PMN in the circulation. L-selectin was cleaved from the surface of the PMN with chymotrypsin following the protocol of Julita et al. (13). Donor blood (75 ml) was obtained, and the PMN were purified and divided into two aliquots that were incubated in either denatured chymotrypsin (control) or chymotrypsin type IV (Sigma) (diluted 1 U/ml containing 3 X lo6 cells/U incubated for 15 min at 37°C). The inability of heat-denatured chymotrypsin to cleave a substrate N-benzoyl+tyrosine ethyl ester was determined in preliminary experiments with a method described by Hummel (12). These studies showed that the ability of chymotrypsin to cleave the substrate was abolished by heating the enzyme for 30 min at 60°C and this denaturing time was used in all subsequent experiments.
The efficiency of L-selectin removal from the PMN surface by chymotrypsin was evaluated by both immunocytochemistry using the APAAP method and by immunofluorescence flow cytometric analysis of the PMN before and after the chymotrypsin treatment (see above). The effect of PMN purification and chymotrypsin treatment on PMN activation was determined by measuring CD18 expression using flow cytometry and cell viability by trypan blue exclusion. No significant changes in CD18 expression or cell viability were observed with either PMN purification alone or after chymotrypsin treatment.
Clearance of Brd U-labeled PMN From Circulation
The BrdU-labeled PMN (PMNBrd") present in 25 ml of donor whole blood (ACD as anticoagulant)
were transfused to each serum-compatible recipient either as whole blood (n = 5) or purified PMN (n = 5). The disappearance of PMNBrd" from the circulation was monitored over a 24-h period by obtaining blood specimens from the central ear artery at baseline (before infusion) at 2.5, 5, 7.5, 10, 15, 20, 30, 45, and 60 min and then hourly for 6 h and at 24 h. The white blood cell counts were determined on a Coulter Counter (model SS80, Coulter), and differential white blood cell counts were determined on Wright's-stained blood smears. The BrdU-labeled PMN was determined with cytospins made from LRP (see above).
To determine the effect of removing L-selectin from the PMN surface, purified PMN from 75 ml of donor blood were diluted in 20 ml PMN buffer. This specimen was divided into two equal aliquots, incubated in either denatured (control) or active chymotrypsin type IV, and infused into the recipients. The disappearance of PMN BrdU from the circulation was monitored over a 24-h period. White blood cell counts and differential white blood cell counts were obtained, and cytospins were made from LRP as described earlier.
L-selectin expression on transfused BrdU-labeled PMN. Cytospins prepared from peripheral blood of recipients were stained for the presence of surface L-selectin and nuclear BrdU by using a double-alkaline phosphatase technique based on the APAAP technique (7). Briefly, the slides were fixed in acetone for 10 min and incubated with 5% rabbit serum for 15 min before the application of the MAb against L-selectin, DREG-200 (5 ug/ml) for 60 min in a humidity chamber at room temperature.
Nonimmune mouse IgG (5 ug/ml) and the omission of the primary antibody were used as negative controls. A 1:20 dilution of rabbit anti-mouse IgG (Dako 2259) was applied for 45 min, followed by the antimouse IgG alkaline phosphatase conjugated complex (Dako D651) in a 1:50 dilution for 45 min. All antibodies were prepared in 50 mM tris(hydroxymethyl)aminomethane (Tris) l Cl, 150 mM NaCl, pH 7.6 (TBS) with 1% bovine serum albumin (BSA), and slides were washed in TBS twice for 10 min between each antibody application.
The alkaline phosphatase was developed for 10 min in the dark with a commercially available kit, HistoMark
Red (Kirkegaard and Perry, Gaithersburg, MD). After a 30-min wash, slides were fixed in methanol for 10 min, which permeabilizes all cell membranes after which the DNA was denatured by incubating slides in 2 N HCl at 37°C for 60 min. The 2 N HCl was neutralized by washing the slides three times with 0.1 M borate buffer, pH 8.5. This step was followed by the second APAAP procedure in which mouse anti-BrdU, 0.1 pg/ml (Boehringer-Mannheim, Mannheim, Germany) was used as the primary antibody.
The slides were washed between antibody applications with 0.1% Tween 20 in TBS (pH 7.6) for 10 min. The alkaline phosphatase was developed with HistoMark Blue for 10 min in the dark. Slides were washed for 30 min in distilled water, mounted in an aqueous medium (Gelvatol), and analyzed on a Zeiss Universal
Research light microscope (model IIR). The influence of the double-labeling procedure on the presence of surface L-selectin and nuclear BrdU expression was evaluated by comparing the number of positive PMN for each antigen after the double-staining procedure with paired slides stained for each single antigen using the APAAP method.
Evaluating PMNBrdu.
The slides were coded, and the PMNBrdu (Fig. lA) were evaluated in computer-generated randomly selected fields counting 100 PMN/slide.
In doublestained slides, the PMNBrdU were identified by a deep blue staining of the cell nucleus (Fig. le) . Cells were categorized as BrdU positive, BrdU and L-selectin positive (double labeled), L-selectin positive, or ncgativc for both labels (Fig.  1B 1 (1) where the fraction PMNkdrJ c,rc 1s the number of PMNBrdU in the circulation as a fraction of the total number of PMNBrdU infused, PMNcirc is the calculated number of PMN (X106) in the circulation (total white blood cell count times the fraction of leukocytes that are PMN), BV is the calculated blood volume, %PMNF&$ent is the fraction of PMNBrdU in a cytospin of peripheral blood in the recipient, and PMNF$,yed is the number (X 106) of PMNBrdv infused [PMN count/ml X vol of fluid infused (ml) x %PMNBrdU]. 
Time
The PMNBrdU were further stratified as either stained for BrdU alone or double stained for BrdU and L-selectin, and these fractions were calculated separately with the same equation.
CaZcuZation of haZf-life of PMNBrdu. The time required to achieve the maximal number of PMNBrdU in the circulating blood of the recipients (&.& was applied to the rate of decay equation to calculate the half-life (t& of PMN in the circulation Nt = Nmaxeekt (2) where Ez is the rate of loss of PMNBrdU from the circulation, t is time after t,,, e is 2.71828, Nt is number of PMNBrdU in the circulation at time t; Nt max is number of PMNBrdU in the circulation at time t,,,. Because the t1/2 can be estimated as the time at which Nt = Nt /2, the rate-decay equation for t1i2 becomes t1/2 = In 2/k. Th>=constant, k, was calculated with the restricted maximum likelihood method described by Feldman (10). The confidence interval (CI) was obtained by deriving the lower and upper bounds of the 95% CI for the slope, k.
Statistical Analysis
Statistical analysis was performed with SYSTAT Version 5.1 software (Systat, Evanston, IL). To evaluate the difference in the behavior of chymotrypsin-treated or control PMNBrdU, the disappearance rate of labeled PMN in each recipient was estimated as the relationship between the fraction of PMNBrdU and time. A log transformation of the fraction of PMNBrdU in the circulation was done and fits a monoexponential line. This family of lines of each group were then compared with the restricted maximum likelihood method (10). The estimates were then compared with a x2 statistic, and differences in slopes, intercepts, and lines were considered significant when P was <0.05, The estimated slope was then used to calculate the half-life for each group (3). A one-way analysis of variance was used to evaluate the changes in L-selectin expression on PMN in the circulation over time, and a two-way analysis of variance was used to compare the transfusion of whole blood with isolated PMN over time.
RESULTS
In Vitro Experiments Figure 2 shows that the expression of L-selectin on PMN decreased to 14.6 t 2.3% of the original baseline value when EDTA whole blood was incubated for 24 h at 37°C in a shaking water bath (Fig. 2K , P < 0.01). Figure 2 shows typical changes in L-selectin (Fig. 2, A-E) and CD18 (Fig. 2, F-J either heparin, EDTA, or ACD was used as anticoagulant (data not shown).
In Vivo Labeling of PMN With BrdU
The staining of PMN for nuclear BrdU and surface L-selectin is shown in Fig. l,A and B. The expression of both L-selectin and BrdU was similar in paired single-( Fig. lA> and d ou e-s ained slides (Fig. 1B) (data not bl t shown>. In donor blood (n = 5), 10.2 5 4.5% of BrdUlabeled PMN stained negative for L-selectin with immunocytochemistry, which is similar to values in animals before BrdU-labeling treatment. Donor animals after 7 days of BrdU treatment have 280% of the circulating PMN labeled. BrdU-labeled donors show the same level of expression of CD18 and L-selectin by flow cytometry (Fig. 3) .
Changes in PMN L-Selectin Expression
To determine the change in L-selectin expression with time in the circulation, PMNHrdU were infused into normal recipients as whole blood. The fraction of L-selectin-negative PMNBrdu increased with time spent in the circulation (Fig. 4 , P < 0.001). The fraction of L-selectin-negative PMNBrdU in the circulation increased rapidly during the first 30 min and then more slowly over the 24-h study period. Nearly all PMN still present in the circulation 24 h after the infusion were negative for L-selectin (Fig. 4) . Similar results were obtained with purified PMNBrciu (n = 5, data not shown).
Effect of L-Selectin Removal on Clearance of PMNB'.tlu From Circulation
To determine whether L-selectin expression influenced clearance of PMN from the circulation, PMNBrdlwere stripped of their L-selectin by chymotrypsin in vitro before their infusion into the recipients (n = 5). The flow cytometric analysis (Fig. 5 , A and F) shows that 78 2 8.2% (n = 5) of the L-selectin present on PMN was removed by chymotrypsin treatment. This loss was confirmed by immunocytochemistry in which the expression of L-selectin on PMN was graded (GO-G4) as previously described (28). The results showed that the PMN that stained intensely positive for L-selectin (G4) decreased from 63 -+ 6.8 to 4.6 5 3% and the negative PMN (GO) increased from 10.2 t 4.5 to 58 t 5.1% with chymotrypsin treatment (n = 5). The viability of PMN, accessed by the trypan blue exclusion, was not changed by chymotrypsin treatment, and the treatment of PMN did not change the expression of CD18 (Fig. 5, E and F) measured by flow cytometry.
The clearance studies showed that the fraction of pMNBrcl17 present in the circulation of recipients directly after infusion was the same in both the control (48 + 12 6%) and the chymotrypsin-treated (46 t 9.6%) -groups. 'The chymotrypsin-treated PMNBrdK disappeared more rapidly from the circulation than control cells during the first hour after infusion but were present in the circulation to the same levels as the nontreated cells by 3 h. The rate of disappearance of PMNBrdrT in the chymotrypsin and control groups between 3 and 24 h was similar (Fig. 6 ) with a similar overall tli2 (262 vs. 296 min) ( Table 1 ). In both the chymotrypsin-treated and control groups, L-selectinpositive PMN appeared to be cleared from the circulation faster than L-selectin negative PMN ( Table 1) The interaction of L-selectin with endothelial cell surface ligands results in rolling and margination of PMN in postcapillary venules. This rolling phenomenon occurs on normal unactivated endothelium (18) but is enhanced on activated endothelium (24). The fraction of PMN rolling increases from ~20% on nonactivated endothelium to >30% on cytokine-activated endothelium with a marked decrease in rolling velocity (18, 24) . The concept that ligand binding initiates receptor shedding provides a mechanism for the return of PMN into the circulation when conditions for firm adhesion and migration are not present. This may be 
